financetom
Business
financetom
/
Business
/
Tesla approves share award worth $29 billion to CEO Elon Musk
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tesla approves share award worth $29 billion to CEO Elon Musk
Aug 4, 2025 3:33 AM

(Reuters) -Tesla has granted CEO Elon Musk 96 million shares worth about $29 billion, a move aimed at keeping the billionaire entrepreneur at the helm as he fights a court ruling that voided his original pay deal for being unfair to shareholders.

In 2024, a Delaware court voided Musk's 2018 compensation package, valued at over $50 billion, citing that the Tesla board's approval process was flawed and unfair to shareholders.

Musk kicked off an appeal in March against the order, claiming a lower court judge made multiple legal errors in rescinding the record compensation.

Earlier this year, the EV maker said the board had formed a special committee to consider some compensation matters involving Musk, without disclosing any details.

Tesla is at a turning point as Musk, its largest shareholder with a 13% stake, shifts focus from a promised affordable EV platform to robotaxis and humanoid robots, positioning the company more as an AI and robotics firm than an automaker.

"While we recognize Elon's business ventures, interests and other potential demands on his time and attention are extensive and wide-ranging ... we are confident that this award will incentivize Elon to remain at Tesla," the special committee said in the filing.

The award is designed to gradually boost Musk's voting power, something he and shareholders have consistently said was key to keeping him focused on Tesla's mission, it added.

Musk must pay Tesla $23.34 per share of restricted stock that vests, which is equal to the exercise price per share of the 2018 CEO Award, it said in the filing.

Tesla shares rose more than 2% in premarket trading.

(Reporting by Aditya Soni in Bengaluru; Editing by Anil D'Silva)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Compass Announces Combination with Anywhere Real Estate in All-Stock Transaction
Compass Announces Combination with Anywhere Real Estate in All-Stock Transaction
Sep 22, 2025
NEW YORK and MADISON, N.J., Sept. 22, 2025 /PRNewswire/ -- Compass, Inc. (Compass) and Anywhere Real Estate Inc. ( HOUS ) (Anywhere) jointly announce the signing of a definitive merger agreement to combine in an all-stock transaction. The combined company is expected to have an enterprise value of approximately $10 billion, including the assumption of debt. This transaction pairs Compass' years...
Patient Square Capital to buy healthcare firm Premier in $2.6 billion deal
Patient Square Capital to buy healthcare firm Premier in $2.6 billion deal
Sep 22, 2025
Sept 22 (Reuters) - Healthcare service provider Premier said on Monday it would be acquired by an affiliate of investment firm Patient Square Capital in a deal valued at about $2.6 billion. ...
Hedge funds pile into banks, insurance, consumer finance, Goldman Sachs says
Hedge funds pile into banks, insurance, consumer finance, Goldman Sachs says
Sep 22, 2025
LONDON (Reuters) -Hedge funds bought banks, insurance and consumer finance companies last week at the fastest pace in three months, Goldman Sachs ( GS ) said in a research note, amid increased dealmaking expected to boost profits and an expected further loosening of regulations. An index of European banks has risen over 40% so far this year, while U.S. banks...
Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio
Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio
Sep 22, 2025
Proposed acquisition to add four highly differentiated clinical-stage incretin and amylin programs to Pfizer’s pipeline Transaction valued at $47.50 per Metsera ( MTSR ) share in cash upon closing, for an initial enterprise value of $4.9 billion with a CVR of up to $22.50 per share in additional payments Pfizer ( PFE ) to host a public webcast at 8...
Copyright 2023-2026 - www.financetom.com All Rights Reserved